Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Clodronic acid
Drug ID BADD_D00494
Description Clodronic acid is a first generation bisphosphonate similar to [etidronic acid] and [tiludronic acid].[A203111] These drugs were developed to mimic the action of pyrophosphate, a regulator of calcification and decalcification.[A1923] clodronate’s use has decreased over the years in favor of the third generation, nitrogen containing bisphosphonate [zoledronic acid], [ibandronic acid], [minodronic acid], and [risedronic acid].[A203111] Clodronic acid is not FDA approved, but is approved in Canada.[L13910]
Indications and Usage Clodronic acid is indicated as an adjunct in the management of osteolysis from bone metastases of malignant tumors and for management of hypercalcemia of malignancy.[L13910]
Marketing Status approved; investigational; vet_approved
ATC Code M05BA02
DrugBank ID DB00720
KEGG ID D03545
MeSH ID D004002
PubChem ID 25419
TTD Drug ID D00HNB
NDC Product Code Not Available
UNII 0813BZ6866
Synonyms Clodronic Acid | Acid, Clodronic | Dichloromethane Diphosphonate | Diphosphonate, Dichloromethane | Dichloromethylenebisphosphonate | Dichloromethanediphosphonic Acid | Acid, Dichloromethanediphosphonic | Dichloromethylene Biphosphonate | Biphosphonate, Dichloromethylene | Dichloromethylene Diphosphonate | Diphosphonate, Dichloromethylene | Cl2MDP | Dichloromethanediphosphonate | Clodronate | Clodronate Disodium | Disodium, Clodronate | Clodronate Sodium | Sodium, Clodronate | Bonefos
Chemical Information
Molecular Formula CH4Cl2O6P2
CAS Registry Number 10596-23-3
SMILES C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Nausea07.01.07.001--
Neoplasm malignant16.16.01.001---
Nephrocalcinosis20.04.01.001---
Oliguria20.01.03.004---
Pharyngitis07.05.07.004; 11.01.13.003; 22.07.03.004--
Pneumonia11.01.09.003; 22.07.01.003---
Proteinuria20.02.01.011--
Pruritus23.03.12.001--
Rash23.03.13.001---
Renal failure20.01.03.005---
Skin disorder23.03.03.007---
Type I hypersensitivity10.01.03.006---
Urethral disorder20.07.01.002---
Urinary tract disorder20.08.01.001---
Urticaria10.01.06.001; 23.04.02.001--
Vomiting07.01.07.003--
Wheezing22.03.01.009--
Foetor hepaticus07.01.06.026; 09.01.05.006---
Protein urine present13.13.02.006---
Hepatic cancer metastatic09.04.02.006; 16.07.02.002---
Connective tissue disorder10.04.04.026; 15.06.01.006---
Mediastinal disorder22.09.03.001---
Decreased appetite08.01.09.028; 14.03.01.005--
Renal impairment20.01.03.010---
Osteonecrosis of jaw15.02.04.010; 24.04.05.005--
Oral disorder07.05.01.005---
Acute kidney injury20.01.03.016--
The 2th Page    First    Pre   2    Total 2 Pages